grants_govRFA-RM-27-002
Open
NIH Director’s New Innovator Award (DP2 Clinical Trial Optional)
- Response deadline
- Aug 17, 2026 Closed
- Date posted
- Jun 26, 2026
- Source
- Open notice
Description
The NIH Director"s New Innovator Award supports early-stage investigators of exceptional creativity who propose bold and highly innovative research projects with the potential to produce a major impact on broad, important areas relevant to the mission of NIH. Applications in any area within the biomedical sciences are welcome; topics may involve basic, translational, or clinical research. The NIH Director's New Innovator Award complements other ongoing efforts by NIH and its Institutes and Centers to fund early-stage investigators. The NIH Director"s New Innovator Award is a component of the High-Risk, High-Reward Research (HRHR) program of the NIH Common Fund.
Classifications
- NAICS93.310
Documents (1)
- DownloadRFA-RM-27-002-Full-Announcement.htmltext/html;charset=UTF-8134 KB
Contacts
Similar contracts
- PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (UG3/UH3 Clinical Trial Optional)Due Oct 19, 2026
- Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (UG3/UH3, Clinical Trial Optional)Due Oct 19, 2026
- Logistics Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U24 Clinical Trials Not Allowed)Due Oct 2, 2026
- Validation Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U54 Clinical Trials Not Allowed)Due Oct 2, 2026
- Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U01 Clinical Trial Not Allowed)Due Oct 9, 2026
- NIH Director’s Transformative Research Award for Individual and Group Science (R01 Clinical Trial Optional)Due Sep 3, 2026